April 14, 2026 Real-Time Surveillance System for Patient Deterioration: A Randomized Controlled Trial
April 6, 2026 Isatuximab Improves MRD Negativity in Newly Diagnosed Multiple Myeloma: Phase 3 IsKia Trial
